SUPPLEMENT FOR USE IN ANIMAL FEED

Information

  • Patent Application
  • 20220174990
  • Publication Number
    20220174990
  • Date Filed
    April 01, 2019
    5 years ago
  • Date Published
    June 09, 2022
    2 years ago
  • Inventors
    • MARTINEZ SANCHEZ; Antonio
    • DIAZ CASTAÑEDA; Maria
  • Original Assignees
Abstract
Supplement for use in animal feed, which consists of a composition intended for animal feed that allows the digestibility of dietary fat to be improved and same to be used at the metabolic level without overloading the hepatic system, comprising a combination of 0.5-5.5% by weight botanicals, 3.0-18.0% by weight vitamins and provitamins, 12.0-25.0% by weight lecithins, 3.0-10.0% by weight sorbitan esters, and 45.0-65.0% antioxidant and adsorbent excipient.
Description
FIELD OF APPLICATION

The field of application of the present invention is in the field of animal feed, with a particular focus on the area of feed manufacturing.


BACKGROUND OF THE INVENTION

The current demand for improvements in productive rates in species intended for production (poultry, pig and aquaculture sectors) implies very high requirements for metabolisable energy in the diet, which can only be met by the supply of fat, as there is no other raw material that contains the energy required by animals for their growth. Therefore, improving the energy efficiency of fats is of great interest from an economic point of view.


Since the 1930s, lecithins, mainly from the soybean oil refining industry, have been used for their fat emulsifying power, and nowadays synthetic emulsifiers (such as glyceryl polyethylene glycol ricinoleate and monoglycerides) and/or natural emulsifiers (such as lysophospholipids) are used to improve the digestibility and absorption of fats and oils at intestinal level.


Mycotoxins, diseases and other factors favour the deterioration of liver function, so the fact that the liver does not function at optimal performance is very common in animal farms. If we add to this a higher fat digestibility that increases the amount of fat that reaches the liver of the animals, the functional capacity of the liver can be exceeded, initiating the process of fat storage inside the hepatocytes and altering their structure and metabolic capacity. If the challenge disappears, we can recover a fatty liver towards a normal, fully functional liver; if not, it will eventually develop into cirrhosis, which will be irreversible.


The use of hepatoprotective substances in the diet of animals will prevent hepatic activity from being compromised, protecting the organ from the challenges it will face and increasing its clearance capacity in different stress situations, leading to improvements in health, growth and production.


There are currently two types of hepatic protectors: those of botanical origin which are formed by combining a variable number of plants with different hepatoprotective properties, and methyl-group donors, among which certain amino acids and their derivatives (e.g. carnitine, betaine, etc.) and vitamin derivatives (e.g. choline) stand out.


The present invention combines liver function enhancers and emulsifiers to achieve an improvement in energy metabolism, combining the emulsifying functionality with that of liver protection and promoting pancreatic, biliary and intestinal secretion, control of liver overload, stimulation of proper fat movement and utilization, improved contact between intestinal substrate and digestive enzymes, and increased liver clearance capacity.


SUMMARY OF THE INVENTION

The present invention relates to a supplement for use in animal feed in order to improve the hepatic metabolism of fats added to animal feed.


More particularly, the object of the present invention is focused on the development of a composition intended for animal feed that allows the digestibility of dietary fat to be improved and the same to be used at the metabolic level without overloading the hepatic system.


The invention essentially consists of a combination of hepatoprotective botanicals, vitamins and provitamins with liver function, lecithins and sorbitan esters.





BRIEF DESCRIPTION OF THE DRAWINGS

In order to clarify the terms of the present invention, reference is made to the figures in which:



FIG. 1.1—depicts a diagram of the evolution of the Conversion Rate (CR) (kg/kg) throughout the trial in laying hens according to treatment.



FIG. 2.2—depicts a diagram of the treatment effect on feed Conversion Rate (CR) throughout the study in broiler chickens.



FIG. 3.3—depicts a diagram of the treatment effect on average daily weight gain (ADG) throughout the study.



FIG. 4.4—depicts a diagram of an anatomopathological study of livers before (A: 69-week-old hens) and after the use of the invention for 11 weeks (B: 80-week-old hens).





DESCRIPTION OF THE INVENTION

The invention is a supplement for use in animal feed, constituting a composition for addition to animal feed in order to improve energy metabolism and reduce energy consumption, which consists of a combination of hepatoprotective botanicals, vitamins and provitamins with liver function, lecithins as a source of natural inositol and choline, and sorbitan esters.


Botanicals are present in a percentage between 0.5% and 5.5% by weight and are chosen from one or more of the group comprising boldo (Peumus boldus), artichoke (Cynara scolymus), turmeric (Curcuma longa), liquorice (Glycyrrhiza glabra), andrographis (Andrographis paniculata), milk thistle (Sylibum marianum), dandelion (Taraxacum officinale) and/or extracts thereof; vitamins and provitamins are chosen from one or more of betaine, choline, methionine, inositol and carnitine and/or their salts and are present between 3.0% and 18.0% by weight; lecithins comprise a mixture of lecithins and hydrolysed soybean and/or sunflower lecithins and are present between 12.0% and 25.0% by weight; sorbitan esters may be monolaurate and/or monooleate and are present between 3.0% and 10.0% by weight; the adsorbent and antioxidant excipient comprises a mixture of silicon dioxide and/or silicic acid, sepiolite and/or sepiolite clay, butylated hydroxytoluene and citric acid and is present between 45.0% and 65.0%.


The invention described in the previous paragraph combines three actions:


It increases intestinal fat absorption through the synergistic action of lecithins and sorbitan esters.


It facilitates the transport of fats to the liver through the action of phospholipids present in lecithins.


It improves the integrity and regeneration of hepatocytes, optimising the liver's detoxification capacity, and promotes hepatic synthesis by stimulating the activity of digestive enzymes which ensure an optimal nutrient utilisation, thanks to the action of botanicals, vitamins and provitamins, and the natural choline and inositol contained in lecithins.


Examples of Compositions of the Invention

The following are three exemplary embodiments of compositions according to the invention which have been shown to be particularly advantageous for use in animal feed.


Example 1

In a first exemplary embodiment, the composition corresponds to the qualitative and quantitative formula given below. The weights of each respective component are for a total composition weight of 1 kg of composition:



















Hydrolysed lecithin
200.00
g



Liquid lecithin
20.00
g



Betaine
25.00
g



Choline Chloride
50.00
g



Carnitine Tartrate
10.00
g



Artichoke extract
10.00
g



Milk Thistle powder
5.00
g



Boldo extract
2.00
g



Sorbitan monooleate
60.00
g



Citric acid anhydrous
10.00
g



BHT
1.00
g



Silicon dioxide
350.00
g



Sepiolite
257.00
g




1000.00
g










For the preparation of the composition of this exemplary embodiment, each of the solid ingredients is weighed and introduced into a mixer provided with agitation, independent liquid inlet and heating mantle. Once all the solid ingredients have been introduced, the stirring is started and the mixture is heated to 45° C. Once this temperature is reached, the liquid mixture, previously heated to 40° C., is slowly added. Once all the liquid mixture has been added, the heating is stopped, the stirring continues for another three minutes and then the mixture is repacked.


Example 2

In this exemplary embodiment, the various components included in the composition according to the invention intervene according to the respective amounts indicated below, for a total composition amount of 1 kg:



















Hydrolysed lecithin
180.00
g



Liquid lecithin
50.00
g



Inositol
30.00
g



Choline Chloride
40.00
g



Carnitine Tartrate
10.00
g



Artichoke extract
10.00
g



Milk Thistle extract
4.00
g



Turmeric extract
4.00
g



Sorbitan monolaurate
75.00
g



Citric acid anhydrous
10.00
g



BHT
1.00
g



Silicic acid
375.00
g



Sepiolite
211.00
g




1000.00
g










For the preparation of the composition of this exemplary embodiment, each of the solid ingredients is weighed and introduced into a mixer provided with agitation, independent liquid inlet and heating mantle. Once all the solid ingredients have been introduced, the stirring is started and the mixture is heated to 45° C. Once this temperature is reached, the liquid mixture, previously heated to 40° C., is slowly added. Once all the liquid mixture has been added, the heating is stopped, the stirring continues for another three minutes and then the mixture is repacked.


Example 3

In this other exemplary embodiment, the components included in the composition according to the invention intervene in the respective quantities indicated below for 1 kg of composition:



















Hydrolysed lecithin
200.00
g



Liquid lecithin
40.00
g



Betaine
20.00
g



Choline Chloride
60.00
g



Inositol
15.00
g



Artichoke extract
5.00
g



Milk Thistle extract
15.00
g



Dandelion powder
5.00
g



Sorbitan monolaurate
50.00
g



Citric acid anhydrous
10.00
g



BHT
1.00
g



Silicic acid
400.00
g



Sepiolite clay
179.00
g




1000.00
g










For the preparation of the composition of this exemplary embodiment, each of the solid ingredients is weighed and introduced into a mixer provided with agitation, independent liquid inlet and heating mantle. Once all the solid ingredients have been introduced, the stirring is started and the mixture is heated to 45° C. Once this temperature is reached, the liquid mixture, previously heated to 40° C., is slowly added. Once all the liquid mixture has been added, the heating is stopped, the stirring continues for another three minutes and then the mixture is repacked.


The different tests carried out have demonstrated the efficacy of use of the invention in improving the feed energy metabolism, as the results obtained suggest that the invention can be used to improve the use of the fats added to the feed, and therefore reduce the percentage of added fats and the cost of the feed.


The following tables show, by way of example, some of the results obtained. In these tables, Lip-DF02 and Lip-DF03 correspond to codifications of the invention for the research trials, and their compositions fall, in both cases, within the ranges stated in the description of the invention. FIGS. 1.1, 2.2 and 3.3, for their part, graphically represent the results of the same trials and FIG. 4.4 shows the histological differences found in the livers after the use of the invention in laying hens.









TABLE 1





Experimental trial with laying hens







Treatments applied



















M. E.





SOYBEAN

ADDITIONAL
TOTAL
LAYING
CRUDE
CRUDE



OIL
Lip-DF02
WHEAT
WHEAT
HENS
PROTEIN
FAT


TREATMENT
(kg/t)
(kg/t)
(kg/t)
(kg/t)
(Mcal/kg)
(%)
(%)





1 CONTROL+
28.0


311.61
2,760
17.1
4.44


2 EXPERIMENTAL
23.0
0.5
4.5
316.11
2,767
17.12
3.96










Conversion Rate (kg/kg) according to treatment












n
CR







1 CONTROL+
64
2.34



2 EXPERIMENTAL
64
2.35











Feed cost differential between treatments













PRICE
CONTROL

EXPERIMENTAL















INGREDIENT
(€/t)
kg/t
Cost €/t
kg/t
Cost €/t







Wheat
184
311
57.224
315.5
58.05



Soybean oil
694
28
19.432
23
15.96



Lip-DFO2
2600


0.5
1.30



Cost €/t


76.656

75.314



Differential




−1.342



(€/t)

















TABLE 2





Experimental trial in broiler chicken fattening







Diets used in the study









EXPERIMENTAL BATCH (T2)











CONTROL BATCH (T1)

ADDITIONAL















SOYBEAN
FAT
Lip-DF02
SOYBEAN
FAT
Lip-DF02
CHOPPED



OIL (kg/t
(kg/t
(kg/t
OIL (kg/t
(kg/t
(kg/t
CORN


DIET
feed)
feed)
feed)
feed)
feed)
feed)
(kg/t feed)





G30(1-7 days)
41.6
0
0
41.6
0
0
0


G31(8-21 days)
27.3
15.1
0
27.3
5.1
1
9


G432(22-30 days)
0
46.3
0
0
36.3
1
9


G300 (31-38 days)
0
46.5
0
0
36.5
1
9










Treatment effect on feed CR













TREATMENT
n
CR (0-7 d)
CR (8-21 d)
CR (22-30 d)
CR (31-38 d)
CR (0-38 d)





CONTROL (T1)
12
1.27
1.43
1.70
1.97
1.64


EXPERIMENTAL (T2)
12
1.30
1.38
1.71
1.98
1.63










Feed cost differential between treatments











FEED 8-21 d
FEED 22-30 d
FEED 31-38 d














CONTROL
EXPERIMENTAL
CONTROL
EXPERIMENTAL
CONTROL
EXPERIMENTAL





















Price

Cost

Cost

Cost

Cost

Cost

Cost


INGREDIENT
(€/t)
kg/t
(€/t)
kg/t
(€/t)
kg/t
(€/t)
kg/t
(€/t)
kg/t
(€/t)
kg/t
(€/t)





Fat
750
15
11.325
5.1
3.825
46
34.725
36
27.225
47
34.875
37
27.375


Corn
180


9
1.620


9
1.620


9
1.620


Lip-
2.6


1
2.600


1
2.600


1
2.600


DF02
€/kg













TOTAL
11.325
8.045
34.725
31.445
34.875
31.595













DIFFERENTIAL





3.280













(€/t)

3.280

 3.280
















TABLE 3





Experimental trial in fattening pigs
















Diets used in the study











EXPERIMENTAL BATCH












CONTROL BATCH

ADDITIONAL













FAT
Lip-DF03
FAT
Lip-DF03
BARLEY


DIET
(kg/t feed)
(kg/t feed)
(kg/t feed)
(kg/t feed)
(kg/t feed)





G-237
15.7
0
10.0
0.4
5.3


(FIRST STAGE


OF FATTENING)


G-557
20.4
0
12.4
0.7
7.3


(GROWING


STAGE)


G-556
20.2
0
15.0
0.4
4.8


(FATTENING


STAGE)










Treatment effect on growth variables














Treatment
n
W0 kg
W56 kg
W96 kg
ADG0-56 g
ADG56-96 g
ADG0-96 g





Control
60
22.01
62.75
106.71
727.21
1099.02
882.13


Experimental
62
22.16
62.83
107.90
728.70
1126.54
894.60










n = No. of pigs, W0 = initial weight, W56 = weight at 56 days, W96 = weight at 96 days


(slaughter), ADG0-56 = average daily weight gain from the start of the experiment to 56


days, ADG56-96 = average daily weight gain between days 56-96, ADG0-96 = average daily


weight gain from the start to the end (slaughter) of the experiment.










Treatment effect on conversion rate










Treatment
CR0-56 Kg/kg
CR56-96 Kg/kg
CR0-96 Kg/kg





Control
2.050
2.296
2.180


Experimental
2.000
2.302
2.170










CR0-56 = feed conversion rate between days 0-56, CR56-96 = feed conversion rate between


days 56-96, CR0-96 = feed conversion rate from the start to the end (slaughter) of the


experiment.











Influence of treatment on carcass characteristics
















Carcass weight
Carcass
Carcass

Classification


Treatment
n
without hands kg
weight kg
Yield %
Muscle %
(scale 1-7)





Control
59
81.03
81.87
76.42
61.47
4.25


Experimental
62
81.22
82.06
75.84
62.27
5.11











n = No. of carcass.



Scale 1-7 from lowest to highest carcass quality.








Claims
  • 1. A supplement for use in animal feed, which consists of a composition for addition to animal feed that allows the digestibility of dietary fat to be improved and same to be used at the metabolic level without overloading the hepatic system, characterized in that it comprises a combination of 0.5-5.5% by weight botanicals, 3.0-18.0% by weight vitamins and provitamins, 12.0-25.0% by weight lecithins, 3.0-10.0% by weight sorbitan esters, and 45.0-65.0% antioxidant and adsorbent excipient.
  • 2. The supplement for use in animal feed as claimed in claim 1, characterized in that the combination of botanicals is chosen from one or more of the group comprising boldo (Peumus boldus), artichoke (Cynara scolymus), liquorice (Glycyrrhiza glabra), andrographis (Andrographis paniculata), turmeric (Curcuma longa), milk thistle (Sylibum Marianum), dandelion (Taraxacum officinale) and/or extracts thereof.
  • 3. The supplement for use in animal feed as claimed in claim 1, characterized in that the vitamins and provitamins are chosen from one or more of betaine, choline, methionine, inositol and carnitine and/or their salts.
  • 4. The supplement for use in animal feed as claimed in claim 1, characterized in that the lecithins comprise a mixture of lecithins and hydrolysed soybean and/or sunflower lecithins.
  • 5. The supplement for use in animal feed as claimed in claim 1, characterized in that the sorbitan esters may be monolaurate and/or monooleate.
  • 6. The supplement for use in animal feed as claimed in claim 1, characterized in that the adsorbent and antioxidant excipient comprises a mixture of silicon dioxide and/or silicic acid, sepiolite and/or sepiolite clay, butylated hydroxytoluene and citric acid.
  • 7. The supplement for use in animal feed as claimed in claim 1, characterized in that it is added to animal feed in a ratio between 250 grams and 2000 grams per tonne of feed.
  • 8. The supplement for use in animal feed as claimed in claim 2, characterized in that it is added to animal feed in a ratio between 250 grams and 2000 grams per tonne of feed.
  • 9. The supplement for use in animal feed as claimed in claim 3, characterized in that it is added to animal feed in a ratio between 250 grams and 2000 grams per tonne of feed.
  • 10. The supplement for use in animal feed as claimed in claim 4, characterized in that it is added to animal feed in a ratio between 250 grams and 2000 grams per tonne of feed.
  • 11. The supplement for use in animal feed as claimed in claim 5, characterized in that it is added to animal feed in a ratio between 250 grams and 2000 grams per tonne of feed.
  • 12. The supplement for use in animal feed as claimed in claim 6, characterized in that it is added to animal feed in a ratio between 250 grams and 2000 grams per tonne of feed.
CROSS REFERENCE TO RELATED APPLICATIONS

This application claims priority from the PCT application number PCT/ES2019/070217 filed on Apr. 1, 2019.

PCT Information
Filing Document Filing Date Country Kind
PCT/ES2019/070217 4/1/2019 WO 00